These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25086280)

  • 1. AMH: An ovarian reserve biomarker in assisted reproduction.
    Peluso C; Fonseca FL; Rodart IF; Cavalcanti V; Gastaldo G; Christofolini DM; Barbosa CP; Bianco B
    Clin Chim Acta; 2014 Nov; 437():175-82. PubMed ID: 25086280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
    La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
    Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
    Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
    Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
    Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
    Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness and indications of AMH assay in women].
    Fouquet A; Catteau-Jonard S; Peigné M; Pigny P; Dewailly D
    Ann Biol Clin (Paris); 2014; 72(6):681-8. PubMed ID: 25486664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti mullerian hormone (AMH)--is it a new reliable marker of the ovarian reserve? Its role in predicting the ovarian response in assisted reproductive technology (ART)].
    Alshiek JA; Lessing JB; Amit A; Azem F
    Harefuah; 2012 Jul; 151(7):416-20, 435. PubMed ID: 23002694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
    Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
    Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success? A prospective data analysis.
    Ficicioglu C; Cenksoy PO; Yildirim G; Kaspar C
    Gynecol Endocrinol; 2014 May; 30(5):372-6. PubMed ID: 24576292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve.
    Tran ND; Cedars MI; Rosen MP
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3609-14. PubMed ID: 21937624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What's new in 2014 about anti-Müllerian hormone?].
    Seroka-Vanhove A; Sonigo C; Roche C; Grynberg M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Oct; 43(8):559-71. PubMed ID: 25042625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing four ovarian reserve markers--associations with ovarian response and live births after assisted reproduction.
    Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
    Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1056-63. PubMed ID: 26184379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between AMH, oocyte number and availability of embryos for cryopreservation in IVF.
    Kotanidis L; Asimakopoulos B; Nikolettos N
    In Vivo; 2013; 27(6):877-80. PubMed ID: 24292596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome.
    Li Y; Nie M; Liu Y; Zhang W; Yang X
    Gynecol Endocrinol; 2015 Jun; 31(6):450-3. PubMed ID: 25585549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
    Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
    Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Level of AMH as a predictor of the result of ovarian stimulation].
    Vrublovský P
    Ceska Gynekol; 2016 Jan; 81(1):23-6. PubMed ID: 26982060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does the serum AMH assay allow predicting reliably female fertility?].
    Rolland AL; Dewailly D
    Gynecol Obstet Fertil; 2015 Oct; 43(10):670-5. PubMed ID: 26388252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone.
    Toner JP; Seifer DB
    Fertil Steril; 2013 Jun; 99(7):1825-30. PubMed ID: 23548941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.